Emilia Kruk

Dr. Emilia Kruk

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2023 in Cancers
Verified
Journal Article
Open access
PDF file
ŁMŁukasz Masior
Łukasz Masior
MKMaciej Krasnodębski
Maciej Krasnodębski
MKMikołaj Kuncewicz
Mikołaj Kuncewicz
KKKacper Karaban
Kacper Karaban
IJIgor Jaszczyszyn
Igor Jaszczyszyn
MGMichał Grąt
Michał Grąt
Transarterial chemoembolization (TACE) is used as a bridging treatment in liver transplant candidates with hepatocellular carcinoma (HCC). Alpha-fetoprotein (AFP) is the main tumor marker used for HCC surveillance. The aim of this study was to assess the potential of using the AFP change after the first TACE in the prediction of complete tumor necrosis. The study comprised 101 patients with HCC who underwent liver transplantation (LT) after TACE in the period between January 2011 and December 2020. The ΔAFP was defined as the difference between the AFP value before the first TACE and AFP either before the second TACE or the LT. The receiver operator characteristics (ROC) curves were used to identify an optimal cut-off value. Complete tumor necrosis was found in 26.1% (18 of 69) and 6.3% (2 of 32) of patients with an initial AFP level under and over 100 ng/mL, respectively (p = 0.020). The optimal cut-off value of ΔAFP for the prediction of complete necrosis was a decline of ≥10.2 ng/mL and ≥340.5 ng/mL in the corresponding subgroups. Complete tumor necrosis rates were: 62.5% (5 of 8) in patients with an initial AFP < 100 ng/mL and decline of ≥10.2 ng/mL; 21.3% (13 of 61) in patients with an initial AFP < 100 ng/mL and decline of 100 ng/mL and decline of ≥340.5 ng/mL; and null in 20 patients with an initial AFP > 100 ng/mL and decline of <340.5 ng/mL, respectively (p = 0.003). The simple scoring system, based on the initial AFP and AFP decline after the first treatment, distinguished between a high, intermediate and low probability of complete necrosis, with an area under the ROC curve of 0.699 (95% confidence intervals 0.577 to 0.821, p = 0.001). Combining the initial AFP with its change after the first treatment enables early identification of the efficacy of TACE.

6 October 2023 in Annals of Transplantation
Verified
Journal Article
Open access
MKMikołaj Kuncewicz
Mikołaj Kuncewicz
IJIgor Jaszczyszyn
Igor Jaszczyszyn
KKKacper Karaban
Kacper Karaban
PRPaweł Rykowski
Paweł Rykowski
MKMaciej Krasnodębski
Maciej Krasnodębski
MGMichał Grąt
Michał Grąt
Background: Malignant and benign neuroendocrine tumors (NET) share many histopathological features. Liver transplantation (LT) is one of the liver-directed therapies for neuroendocrine liver metastases (NELM). The aim of this study was to determine the outcomes of patients undergoing LT for NELM. Material/Methods: This was a retrospective study that included 19 patients who underwent LT for unresectable NELM between December 1989 and December 2022 in the Department of General, Transplant, and Liver Surgery of the Medical University of Warsaw. Kaplan-Meier estimator and Cox proportional hazards regression were used for statistical analyses.Results: The primary tumor was located most frequently in the pancreas. The median follow-up was 72.5 months. The overall survival (OS) was 94.7%, 88.0%, 88.0%, 70.4%, and 49.3% after 1, 3, 5, 10, and 15 years, respectively. Accordingly, the recurrence-free survival (RFS) rates were 93.8%, 72.9%, 64.8%, 27.8%, and 27.8% after 1, 3, 5, 10, and 15 years, respectively. Ki-67 index >= 5% was found as a risk factor for both worse OS (hazard ratio (HR) 7.13, 95% confidence intervals (95% CI) 1.32-38.63, P=0.023) and RFS (HR 13.68, 95% CI 1.54-121.52, P=0.019). Recipient age >= 55 years was a risk factor for worse RFS (P=0.046, HR 5.47, 95% CI 1.03-29.08). Multivariable analysis revealed Ki-67 >= 5% as the sole independent factor for worse OS (HR 13.78, 95% CI 1.48-128.56, P=0.021).Conclusions: Patients with unresectable NELM achieve great OS and satisfying RFS after LT. The risk factors associated with worse outcomes are attributed to primary tumor aggressiveness.

14 August 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
EKEmilia Kruk
Emilia Kruk
PKPiotr Kalinowski
Piotr Kalinowski
KGKrzysztof Gibiński
Krzysztof Gibiński
KDKrzysztof Dudek
Krzysztof Dudek
MSMichał Skalski
Michał Skalski
MGMichał Grąt
Michał Grąt
In liver transplantation, a side-to-side anastomosis is one of the commonly performed techniques of the inferior vena cava reconstruction. The authors report a case of an application of an endoscopic vascular linear stapler for a side-to-side caval anastomosis during deceased-donor liver transplantation. The back table procedure was performed in a standard fashion for a side-to-side anastomosis. The linear vascular stapler was introduced during the temporary clamping of the recipient’s inferior vena cava and the anastomosis was created without problems. Suturing of the resulting defect completed the anastomosis. The use of the stapler resulted in a shortening of the anastomosis time. The staple line after the reperfusion of the graft was completely sealed. The patient’s postoperative course was uncomplicated and post-operative ultrasound and computed tomography confirmed the patency of the anastomosis. This case demonstrates a novel approach to a side-to-side caval reconstruction during liver transplantation that enables a shortening of the implantation time and may improve the quality of anastomoses.

31 December 2024 in Annals of Transplantation
Verified
Journal Article
Open access
EKEmilia Kruk
Emilia Kruk
MKMaciej Krasnodębski
Maciej Krasnodębski
PRPaweł Rykowski
Paweł Rykowski
WFWojciech Figiel
Wojciech Figiel
WHWacław Hołówko
Wacław Hołówko
MGMichał Grąt
Michał Grąt
Survival Analysis of Liver Transplants in Patients with Acute Liver Failure from Acetaminophen and Mushroom Toxicity - Article abstract #946485

29 October 2026 in The Lancet Regional Health - Europe
Verified
Journal Article
Open access
AAAlfonso W Avolio
Alfonso W Avolio
MPMarco Maria Pascale
Marco Maria Pascale
QLQuirino Lai
Quirino Lai
PBPatrizia Burra
Patrizia Burra
UCUmberto Cillo
Umberto Cillo
VAVatche G. Agopian
Vatche G. Agopian

8 February 2024 in Liver Transplantation
Verified
Journal Article
Closed access
PKPiotr Kalinowski
Piotr Kalinowski
EKEmilia Kruk
Emilia Kruk
MGMichał Grąt
Michał Grąt
An abstract is unavailable. This article is available as a PDF only.